USTEKINUMAB DRUG EXPOSURE IS NOT LINKED TO CHANGES IN BOWEL WALL THICKNESS, BUT DOES ASSOCIATE WITH TRANSMURAL REMISSION IN CROHN’S DISEASE

Bram Verstockt  ¹     Christian Maaser  ²     Rune Wilkens  ³     Giovanni Maconi  ⁴     Maria Antonietta D’Agostino  ⁵     Maciej Nazar  ⁶     Marjolein Lahaye  ⁷     Omoniyi J. Adedokun  ⁸     Manuela Le Bars  ⁹     Ivana Bravatà  ¹⁰     Lioudmila Ni  ¹¹     Mariangela Allocca  ¹²     Floris A. E. de Voogd  ¹³     Carolina Palmela  ¹⁴     Rose Vaughan  ¹⁵     Torsten Kucharzik  ^15    
1 Department of Gastroenterology and Hepatology, Leuven, Belgium
² Klinik für Allgemeine Innere Medizin und Gastroenterologie, Lüneburg, Germany
³ Gastro Unit, Copenhagen, Denmark
⁴ Gastroenterology Unit, Milan, Italy
⁵ Rheumatology Unit, Rome, Italy
⁶ Janssen-Cilag Polska Sp. z .o.o, Warsaw, Poland
⁷ Janssen-Cilag B.V., Breda, Netherlands
⁸ Janssen Research & Development, Pennsylvania
⁹ Janssen-Cilag, Issy-les-Moulineaux, France
¹⁰ Janssen-Cilag S.p.A., Milan, Italy
¹¹ Janssen-Cilag Russia, Moscow, Russian Federation
¹² Department of Gastroenterology, Milan, Italy
¹³ Department of Gastroenterology and Hepatology, Amsterdam, Netherlands
¹⁴ Division of Gastroenterology, Loures, Portugal
¹⁵ Gastroenterology Department, Melbourne, Australia

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)